Microbix Biosystems, Inc.

Click Here To EMAIL INQUIRY
Contact: Kevin Koole - International & National Sales Manager
Web: http://www.microbix.com
E-Mail:
Address: 265 Watline Avenue, Mississauga, Ontario L4Z 1P3, Canada
Phone: +1-(416)-234-1624, 800-794-6694 | Fax: +1-(416)-234-1626 | Map/Directions >>

Profile: Microbix Biosystems, Inc. specializes in developing biological technologies. We have a pipeline of products in three areas such as bio therapeutics, vaccines and non-therapeutic biologic. We offer urokinase for bio therapeutics, ViruSmax™ and SST. We specialize in adeno virus kits, antigens and antibodies. Our adenovirus kids include AdMax™, AdMax Hi-IQ, helper dependent adenovirus and adcre. The AdMax-Hi IQ system is combined with the AdMax II plasmid vector rescue system for isolation of vectors expressing toxic proteins at ultra high levels. The system differs from the original AdMax only in its use of 293 cells expressing lac repressor and shuttle plasmids containing expression cassettes with the MCMV IE gene promoter.

The company has revenues of USD 1-5 Million, has ~40 employees and is ISO certified. TSE:MBX (SEC Filings)

6 Products/Services (Click for related suppliers)

• Control Antiserum/Antigen

• Cytomegalovirus IHA Antigen Test (FDA Code: LJO / 866.3175)

Cytomegalovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to cytomegalovirus in serum. The identification aids in the diagnosis of diseases caused by cytomegaloviruses (principally cytomegalic inclusion disease) and provides epidemiological information on these diseases. Cytomegalic inclusion disease is a generalized infection of infants and is caused by intrauterine or early postnatal infection with the virus. The disease may cause severe congenital abnormalities, such as microcephaly (abnormal smallness of the head), motor disability, and mental retardation. Cytomegalovirus infection has also been associated with acquired hemolytic anemia, acute and chronic hepatitis, and an infectious mononucleosis-like syndrome.

• Rubella Antigen (FDA Code: LSJ / 866.3510)

Rubella virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rubella virus in serum. The identification aids in the diagnosis of rubella (German measles) or confirmation of a person's immune status from past infections or immunizations and provides epidemiological information on German measles. Newborns infected in the uterus with rubella virus may be born with multiple congenital defects (rubella syndrome).

• Rubella Assays (FDA Code: LSD / 866.3510)

• Toxoplasma Gondii Antibody Test

• Toxoplasma Gondii IF Antigen Test (FDA Code: GLZ / 866.3780)